Introduction
- 19 February 2001
- journal article
- editorial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 110 (3), 1-2
- https://doi.org/10.1016/s0002-9343(00)00676-8
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgiaArthritis & Rheumatism, 2000
- Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs.Jama-Journal Of The American Medical Association, 1999
- Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid ArthritisJama-Journal Of The American Medical Association, 1999
- Treatment of Osteoarthritis With Celecoxib, a Cyclooxygenase-2 Inhibitor: A Randomized Controlled TrialMayo Clinic Proceedings, 1999
- Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain modelClinical Pharmacology & Therapeutics, 1999
- Cyclooxygenase in biology and diseaseThe FASEB Journal, 1998
- Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effectsArthritis & Rheumatism, 1998